Schedule 13G ownership disclosure

RTI Biologics, Inc.

Security class unavailable · CUSIP: 74975N105

Event date: 2020-01-14

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
4,650,452
Percent of class
6.3000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-20-003963
Form type
SC 13G
Filer
Glen Capital Partners Focus Fund, L.P.
CIK
CIK 1572382
Filed
Jan 14, 2020
Reporting period
Jan 14, 2020
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub